Earningsreport

Q2/2018 6/30/2018 EPS -0.150 ZacksConsensus -0.120 ActVsEst (0.030) - Miss

TherapeuticsMD, Inc.  (TXMD) 
NASDAQ:AMEX Investor Relations: ir.therapeuticsmd.com